Table 3.
Analyzed fatty acid composition of experimental diets in experiment 11
| O3 trial feed, % | |||||
|---|---|---|---|---|---|
| Fatty acid, % | 0 | 1 | 2 | 3 | 4 |
| Phase 1 (days 0 to 13) | |||||
| Total fatty acids | 4.21 | 4.34 | 4.72 | 4.96 | 4.89 |
| Total fat | 4.68 | 4.82 | 5.25 | 5.51 | 5.44 |
| Omega-6:3 | 18.57 | 9.56 | 6.44 | 4.94 | 4.07 |
| C16:0 | 0.61 | 0.61 | 0.64 | 0.66 | 0.64 |
| C18:1n9c | 1.01 | 1.01 | 1.10 | 1.15 | 1.12 |
| C18:2n6c2 | 2.26 | 2.25 | 2.36 | 2.11 | 2.32 |
| C18:3n33 | 0.12 | 0.24 | 0.37 | 0.49 | 0.57 |
| Phase 2 (days 13 to 22) | |||||
| Total fatty acids | 3.95 | 3.97 | 4.64 | 4.53 | 4.56 |
| Total fat | 4.39 | 4.41 | 5.15 | 5.04 | 5.06 |
| Omega-6:3 | 15.03 | 9.60 | 5.38 | 4.29 | 3.78 |
| C16:0 | 0.57 | 0.56 | 0.61 | 0.59 | 0.58 |
| C18:1n9c | 0.89 | 0.88 | 1.03 | 0.98 | 0.98 |
| C18:2n6c | 2.14 | 2.11 | 2.31 | 2.21 | 2.17 |
| C18:3n3 | 0.14 | 0.22 | 0.43 | 0.52 | 0.58 |
| Phase 3 (days 22 to 41) | |||||
| Total fatty acids | 4.47 | 4.77 | 5.01 | 4.49 | 4.71 |
| Total fat | 4.96 | 5.30 | 5.61 | 4.99 | 5.23 |
| Omega-6:3 | 20.69 | 10.11 | 6.71 | 4.86 | 3.80 |
| C16:0 | 0.66 | 0.67 | 0.68 | 0.61 | 0.61 |
| C18:1n9c | 1.06 | 1.11 | 1.18 | 0.99 | 1.03 |
| C18:2n6c | 2.36 | 2.46 | 2.53 | 2.17 | 2.20 |
| C18:3n3 | 0.11 | 0.24 | 0.38 | 0.45 | 0.58 |
1Complete diets contained trace levels of C12:0, C14:0, C15:0, C16:1n7, C17:0, C18:0, C18:1n9t, C18:1n7c, C18:3n6, CLA 9c, 11t (n7), C20:0, C20:2n6, C22:0, C23:0, and C24:0 of < 0.10%. Other fatty acid levels were too low to be detected in the analysis.
2Major omega-6 fatty acids.
3Major omega-3 fatty acids.